Abstract
Elevated factor VII (FVII) level is a risk factor for coronary artery disease (CAD). We investigated the role of R353Q polymorphism in the F7 gene in 139 Indian families with CAD, comprising of 222 affected subjects, 105 unaffected subjects and 126 affected sibling pairs. Plasma per cent FVIIc activity (FVII.c activity) differed significantly across R353Q genotype (P < 0.0001). Frequency of subjects with RR and QQ genotypes were higher in 4th quartile and 1st quartile of FVII.c activity, respectively (P < 0.0001). F7 R353Q SNP was able to explain up to 7% of variation in FVII.c activity by regression analysis and an additive genetic component of variance of 28.04% by heritability analysis. Quantitative trait loci analysis showed suggestive linkage evidence of F7 SNP with per cent FVII.c activity (LOD score −1.82; P = 0.002). Individuals with RR and RQ genotypes carried an OR of 2.071 (95% c.i. = 1.506−2.850) and 2.472 (95% c.i. = 1.679−3.641), respectively, towards CAD risk. There was significant correlation of FVII.c activity with lipid markers, particularly among those with RR and RQ genotype after covariate adjustment. In conclusion, the F7 R353Q SNP appears to moderately influence plasma FVII.c activity and risk of CAD in Indians.
Similar content being viewed by others
References
Abecasis G. R., Cherny S. S., Cookson W. O. and Cardon L. R. 2002 Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 30, 97–101.
Balleisen L., Bailey J., Epping P. H., Schulte H. and van de Loo J. 1985 Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb. Haemostasis 54, 475–479.
Batalla A., Alvarez R., Reguero J. R., Gonzalez P., Alvarez V., Cubero G. I. et al. 2001 Lack of association between polymorphisms of the coagulation factor VII and myocardial infarction in middle-aged Spanish men. Int. J. Cardiol. 80, 209–212.
Bernardi F., Arcieri P., Bertina R. M., Chiarotti F., Corral J., Pinotti M. et al. 1997 Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. Arterioscler. Thromb. Vasc. Biol. 17, 2548–2553.
Blackwelder W. C. and Elston R. C. 1985 A comparison of sib-pair linkage tests for disease susceptibility loci. Genet. Epidemiol. 2, 85–97.
Doggen C. J., Manger Cats V., Bertina R. M., Reitsma P. H., Vandenbroucke J. P. and Rosendaal F. R. 1998 A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men. Thromb. Haemostasis 80, 281–285.
Elston R. C. and Gray-McGuire C. 2004 A review of the statistical analysis for genetic epidemiology (SAGE) software package. Hum. Genomics 1, 456–459.
Feng D., Tofler G. H., Larson M. G., O’Donnell C. J., Lipinska I., Schmitz C. et al. 2000 Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart Study. Arterioscler. Thromb. Vasc. Biol. 20, 593–600.
Green F., Kelleher C., Wilkes H., Temple A., Meade T. and Humphries S. 1991 A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler. Thromb. Vasc. Biol. 11, 540–546.
Humphries S. E., Lane A., Green F. R., Cooper J. and Miller G. J. 1994 Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler. Thromb. Vasc. Biol. 14, 193–198.
Junker R., Heinrich J., Schulte H., van de Loo J. and Assmann G. 1997 Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler. Thromb. Vasc. Biol. 17, 1539–1544.
Kruglyak L., Daly M. J., Reeve-Daly M. P. and Lander E. S. 1996 Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58, 1347–1363.
Lane A., Green F., Scarabin P. Y., Nicaud V., Bara L., Humphries S. et al. 1996 Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis 119, 119–127.
Liu Y., Heng C. K., Saha N., Hong S. and Low P. S. 2002 Genotype associations of factor VII gene with plasma factor VII coagulant activity and antigen levels in healthy Chinese. Blood Coagul. Fibrinolysis 13, 217–224.
Meade T.W., North W. R., Chakrabarti R., Haines A. P. and Stirling Y. 1977 Population-based distributions of haemostatic variables. Br. Med. Bull. 33, 283–288.
Meade T.W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R. et al. 1986 Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet 2, 533–537.
Miller S. A., Dykes D. D. and Polesky H. F. 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nuclic Acids Res. 16, 1215.
Mukhopadhyay N., Almasy L., Schroeder M., Mulvihill W. P. and Weeks D. E. 2005 Mega2: data-handling for facilitating genetic linkage and association analyses. Bioinformatics 21, 2556–2557.
Rao L. V. and Rapaport S. I. 1988 Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc. Natl. Acad. Sci. USA 85, 6687–6691.
Reiner A. P., Carlson C. S., Rieder M. J., Siscovick D. S., Liu K., Chandler W. L. et al. 2007 Coagulation factor VII gene haplotypes, obesity-related traits, and cardiovascular risk in young women. J. Thromb. Haemostasis 5, 42–49.
SAGE 2005 Statistical analysis for genetic epidemiology. Case Western Reserve University, Cleveland, USA.
Saha N., Liu Y., Heng C. K., Hong S., Low P. S. and Tay J. S. 1994 Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides. Arterioscler. Thromb. Vasc. Biol. 14, 1923–1927.
Scarabin P. Y., Vissac A. M., Kirzin J. M., Bourgeat P., Amiral J., Agher R. et al. 1996 Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII. Arterioscler. Thromb. Vasc. Biol. 16, 1170–1176.
Soria J. M., Almasy L., Souto J. C., Sabater-Lleal M., Fontcuberta J. and Blangero J. 2005 The F7 gene and clotting factor VII levels: dissection of a human quantitative trait locus. Hum. Biol. 77, 561–575.
Thompson S. G., Martin J. C. and Meade T. W. 1987 Sources of variability in coagulation factor assays. Thromb. Haemostasis 58, 1073–1077.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shanker, J., Perumal, G., Maitra, A. et al. Genotype-phenotype relationship of F7 R353Q polymorphism and plasma factor VII coagulant activity in Asian Indian families predisposed to coronary artery disease. J Genet 88, 291–297 (2009). https://doi.org/10.1007/s12041-009-0042-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-009-0042-x